GLP-1 receptor agonists (RA) may increase the risk of non-arteritic anterior ischemic optic neuropathy (NAION), although the absolute risk is low. Studies supporting the association have reported ...
GLP-1 RAs are linked to an increased risk of NAION in type 2 diabetes patients, with semaglutide and liraglutide showing significant associations. The study involved over 3.8 million Medicare patients ...
Federal courts have recently taken a significant step in the growing litigation involving Ozempic and similar diabetes and weight loss drugs. Lawsuits alleging that these medications – known as GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results